Latest Investor Presentations News

SomnoMed Limited prepares to unveil its H1FY25 financial results on February 28, 2025, accompanied by a live investor presentation and Q&A session. The company remains a global leader in sleep apnea treatment solutions.

Microba Life Sciences reports a remarkable 102% revenue increase in Q2 FY25, driven by strong sales of its MetaXplore test in Australia and promising early traction in the UK. The company also advances its therapeutic pipeline with key clinical milestones.

Kincora Copper Limited has unveiled an updated investor presentation outlining its aggressive push towards Tier-1 copper-gold discoveries, backed by over $60 million in partner funding and ramped-up drilling programs across New South Wales and Mongolia.